Further evaluation of the dynamics of CD8+ TRM during infections with a strong pro-inflammatory profile could provide insight into how overt inflammation may affect long-term immunity and inform of specific therapeutics targeting NFkB or its pro-inflammatory drivers to either boost or deplete tissue-resident memory. This evidence concerns the gene NFKB1 and infection.